Prostate Cancer Clinical Practice Guidelines in Oncology

Abstract

Although the incidence of prostate cancer has been increasing (1.4% annually from 1995 to 1999), the age-adjusted death rates from prostate cancer have begun to decline (-4.3% annually from 1994 to 1999), and researchers expect prostate cancer to account for only 28,900 deaths in 2003. This suggests that unless prostate cancer is becoming biologically less aggressive, increased public awareness with earlier detection and treatment of prostate cancer has begun to make an impact on this prevalent disease. To properly identify and manage patients with prostate cancer or any malignancy, physicians must have an in-depth understanding of the natural history and treatment options. To this end, an NCCN panel of leading experts from the fields of urology, radiation oncology, and medical oncology at member institutions was appointed to develop guidelines for the treatment of prostate cancer. For the most recent version of the guidelines, please visit NCCN.org